Official Name: Medtronic plc

Headquarters: Dublin, Ireland

Founded: 2001 

Employees: 90,000

CEO: Mr. Geoffrey Straub Martha

NYSE: MDT -0.69%

Market Cap

$111.60 Billion

USD as of Jan. 1, 2024

Market Cap History

Medtronic market capitalization over time

Evolution of Medtronic plc market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Medtronic plc

Detailed Description

Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Top 1-year algo backtest: +181.22%

$10,000 in June 2023 would now be $28,122 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Product & Services

Medical devices

Key People

Founder(s): Moshe Shoham, Eli Zehavi

Ori Hadomi, CEO


Revenue: (FY 28 April 2017)US$30.8 billion

Operating income: US$ 5.33 billion(FY 28 April 2017)

Net income: US$ 4.02 billion(FY 28 April 2017)

Total assets: US$ 99.82 billion(FY 28 April 2017)

Total equity: US$ 50.29 billion(FY 28 April 2017)



20 On Hatch

Lower Hatch Street

Dublin, 2


Phone: 353 1 438 1700